AzTrials
AzTrials

Colon CancerPhase 2NCT01042743

Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial

A Phase 2 study testing robot-assisted surgery and laparoscopic right-hemicolectomy in people with Colon Cancer, run by Kyungpook National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The recent introduction of robotic surgical system has revolutionized the field of minimally invasive surgery. The investigators hypothesized that adoption of a robotic surgical system for patients with right-side colon cancer seems appealing because This system provides high-definition three-dimensional vision… Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Colon Cancer
What is being tested?
robot-assisted surgery and laparoscopic right-hemicolectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteSouth Korea
Study dates
Jan 2010to Dec 2011
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary cancer
  • right-side located tumor (from cecum to proximal transverse colon)

Who cannot join

  • tumor with obstruction
  • tumor with perforation
  • clinically advanced tumor (T4 stage)
  • tumor with distant metastases
  • synchronous tumor

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Kyungpook National University Hospital

    Daegu, 700-721

Other trials in South Korea

About this study

The recent introduction of robotic surgical system has revolutionized the field of minimally invasive surgery. The investigators hypothesized that adoption of a robotic surgical system for patients with right-side colon cancer seems appealing because This system provides high-definition three-dimensional vision, eliminates physiologic tremor, and better ergonomics. This randomized controlled trial was designed to determine the safety and efficacy of robotic right hemicolectomy in comparison with laparoscopic right hemicolectomy.

Conditions
Colon Cancer
Being tested
robot-assisted surgery, laparoscopic right-hemicolectomy
Keywords
colon cancer, robot, laparoscopy, primary, right-side colon cancer, robot-assisted surgery
Medical subject headings
Colonic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • robot-assisted surgeryProcedure or surgery

    da Vinci surgical system® (Intuitive Surgical, Sunnyvale, CA, USA)

  • laparoscopic right-hemicolectomyProcedure or surgery

    Conventional laparoscopic procedures

Study groups in NCT01042743
Study groupRoleWhat they receive
RAPExperimentalindividuals who underwent robot-assisted surgery for primary right-sied colon cancer
Receives: Procedure: robot-assisted surgery
LAPActive comparatorIndividuals who underwent laparoscopic surgery for primary right-side colon cancer
Receives: Procedure: laparoscopic right-hemicolectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. surgical quality based on pathological examination

    Measured: during perioperative period (1-30 days after operation)

Secondary outcomes (1)
  1. complication

    Measured: during perioperative period ( 1-30 days after primary operation)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2010 (estimated)
  2. Study startJan 2010
  3. Primary completionDec 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01042743
Sponsor's protocol ID
KNUHCRC001
Status last verified
Dec 2011
First submitted
5 Jan 2010
Last updated
20 Dec 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Park JS, Lee SM, Choi GS, Park SY, Kim HJ, Song SH, Min BS, Kim NK, Kim SH, Lee KY. Comparison of Laparoscopic Versus Robot-Assisted Surgery for Rectal Cancers: The COLRAR Randomized Controlled Trial. Ann Surg. 2023 Jul 1;278(1):31-38. doi: 10.1097/SLA.0000000000005788. Epub 2023 Jan 3.

    PubMed 36594748
  • Park JS, Choi GS, Park SY, Kim HJ, Ryuk JP. Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg. 2012 Sep;99(9):1219-26. doi: 10.1002/bjs.8841.

    PubMed 22864881

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing robot-assisted surgery and laparoscopic right-hemicolectomy in people with Colon Cancer, run by Kyungpook National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Dec 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

surgical quality based on pathological examination (time frame: during perioperative period (1-30 days after operation)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01042743, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in